Donald Trump’s administration is stepping up attacks on US trading partners over drug pricing, preparing a new probe that would lay the ground for a fresh barrage of tariffs.
The imminent investigation, which would come under Section 301 of the Trade Act of 1974, would consider whether any US trading partners are underpaying for drugs, said three people familiar with the matter.
Trump has repeatedly complained other countries pay less than the US for medicines and signalled he would take trade actions against nations that refused to “equalise”.
您已阅读17%（548字），剩余83%（2663字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。